Mechanism of Action of Sitagliptin
Introduction Sitagliptin is an oral dipeptidyl peptidase‑4 (DPP‑4) inhibitor used to manage type 2 diabetes mellitus (T2DM). It … Read more
moa blog
Mechanism of Action of Vortioxetine
Introduction Vortioxetine is a multimodal antidepressant approved for major depressive disorder (MDD). It uniquely combines serotonin transporter (SERT) … Read more
Mechanism of Action of Natalizumab (Tysabri)
Introduction Natalizumab is a humanized IgG4 monoclonal antibody targeting the α4 integrin subunit. It’s approved for relapsing-remitting multiple … Read more
Mechanism of Action of Remdesivir (Veklury)
Introduction Remdesivir is an intravenous antiviral prodrug that inhibits viral RNA-dependent RNA polymerase (RdRp). Originally developed for Ebola, … Read more
Mechanism of Action of Adalimumab (Humira)
Introduction Adalimumab is a fully human monoclonal IgG1 antibody that specifically targets tumor necrosis factor‑α (TNF‑α). By neutralizing … Read more
Mechanism of Action of Entyvio (Vedolizumab)
Introduction Entyvio (vedolizumab) is a recombinant humanized IgG1 monoclonal antibody that targets the α4β7 integrin on gut-homing T-lymphocytes. … Read more
Mechanism of Action of Etanercept (Enbrel)
Introduction Etanercept is a biologic fusion protein that functions as a soluble tumor necrosis factor (TNF) receptor. By … Read more
Mechanism of Action of Tofacitinib (Xeljanz)
Introduction Tofacitinib is an oral Janus kinase (JAK) inhibitor, primarily targeting JAK1 and JAK3. It blocks intracellular signaling … Read more
Mechanism of Action of Liraglutide
Introduction Liraglutide is a long-acting GLP‑1 receptor agonist, injected once daily. It’s used for type 2 diabetes mellitus … Read more
Mechanism of Action of SGLT2Inhibitors
Introduction SGLT2 inhibitors, also known as “gliflozins,” are a class of oral antidiabetic agents primarily used to manage … Read more